💉 J&J’s attempt to extend TB drug patent in India rejected; Genentech’s biologics plant winds down; Moderna moves beyond Covid
#304 | TB or not TB? Malaria vaccine coverage expands, baby; Water insecurity gives us the heebie-jeebies
Hello again. Today, at The Kable, we’re wrapping up this week with a heightened focus on tuberculosis since today is World TB Day.
On this occasion, we can celebrate the end of a monopoly on drug-resistant TB drug Bedaquiline in India come July, as the country’s patent office denied Johnson & Johnson’s application for a patent extension until 2027.